Technical Analysis for ILMN - Illumina, Inc.

Grade Last Price % Change Price Change
A 421.0 3.63% 14.75
ILMN closed up 3.63 percent on Monday, January 25, 2021, on 1.53 times normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Earnings due: Feb 11
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical ILMN trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
New 52 Week High Strength 0.00%
Upper Bollinger Band Walk Strength 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Up 5 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
New 52 Week Closing High Bullish 3.63%
Older End-of-Day Signals for ILMN ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
1.5x Volume Pace about 17 hours ago
60 Minute Opening Range Breakout about 18 hours ago
Up 3% about 18 hours ago
Up 1 ATR about 18 hours ago
Up 2% about 19 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Illumina, Inc. Description

Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation and biological function in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa. Its sequencing platforms include HiSeq 2000, an instrument for high-throughput sequencing using sequencing by synthesis (SBS) technology; HiSeq 1500 that accommodates lower throughput needs; and MiSeq Personal Sequencing System that offers sequencing applications in a compact and economical instrument for individual researchers. The company's sequencing/array combination platforms comprise HiScanSQ that combines SBS technology and HiScan microarray analysis instrumentation into one system. Its array platforms consist of HiScan and iScan systems that are array scanners, which support the imaging of its array-based genetic analysis products. The company also offers various sample preparation and sequencing kits, such as standard sequencing kits; Infinium assay kits; paired-end genomic deoxyribonucleic acid (DNA) sample prep kits; and TruSeq SBS sequencing kits, as well as library preparation kits. In addition, it provides InfiniumHD Whole-Genome BeadChips, which are multi-sample DNA analysis microarrays; HumanOmni5-Quad, HumanOmni2.5, and HumanOmni1S BeadChips; agriculturally relevant genome panels; and iSelect Custom Genotyping BeadChips. Further, it offers CytoChip, a test for the investigation of genetic abnormalities associated with developmental delay or with complex leukemia's; Eco Real-Time polymerase chain reaction system; and sequencing and genotyping services. The company serves genomic research centers, academic institutions, government laboratories, and clinical research organizations, as well as pharmaceutical, biotechnology, agri-genomics, and consumer genomics companies. It sells its products directly and through distributors. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Life Sciences Biology Acid Imaging Telemedicine Telehealth Molecular Biology Clinical Research Lab Testing Genomics Scanner Library Genome Illumina Polymerase Chain Reaction Genotyping DNA Sequencing DNA Chip

Is ILMN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 425.71
52 Week Low 196.78
Average Volume 1,076,832
200-Day Moving Average 342.95
50-Day Moving Average 350.01
20-Day Moving Average 379.17
10-Day Moving Average 386.90
Average True Range 12.62
ADX 42.62
+DI 41.51
-DI 8.62
Chandelier Exit (Long, 3 ATRs ) 387.84
Chandelier Exit (Short, 3 ATRs ) 393.87
Upper Bollinger Band 412.53
Lower Bollinger Band 345.82
Percent B (%b) 1.13
BandWidth 17.59
MACD Line 15.10
MACD Signal Line 11.78
MACD Histogram 3.321
Fundamentals Value
Market Cap 61.47 Billion
Num Shares 146 Million
EPS 4.31
Price-to-Earnings (P/E) Ratio 97.59
Price-to-Sales 13.92
Price-to-Book 9.44
PEG Ratio 1.92
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 449.47
Resistance 3 (R3) 447.88 436.79 444.73
Resistance 2 (R2) 436.79 429.54 437.59 443.14
Resistance 1 (R1) 428.90 425.06 432.85 430.49 441.56
Pivot Point 417.81 417.81 419.79 418.61 417.81
Support 1 (S1) 409.92 410.56 413.87 411.51 400.44
Support 2 (S2) 398.83 406.08 399.63 398.86
Support 3 (S3) 390.94 398.83 397.28
Support 4 (S4) 392.53